Financial Daily from THE HINDU group of publications
Saturday, Aug 21, 2004

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Announcements


Neuland facility gets USFDA nod

Our Bureau

HYDERABAD: Neuland Laboratories Ltd (NLL), the city-based pharmaceutical company, has informed the stock exchanges that the United States Food and Drug Administration (USFDA) authorities have approved the company's entire manufacturing facility located at nearby Bonthapally. The company said it received a letter from USFDA dated August 10.

More Stories on : Announcements | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
IVRCL to raise Rs 150 cr via book-building


Neuland facility gets USFDA nod
Indian Hotels ED quits
GE Shipping adds to fleet
ESPN-Star, Zee in slanging match over cricket telecast
Coca-Cola is `best pvt co'
Corporate sector deserves better treatment
Fenner completes business restructuring
Vedanta to buy 51 pc stake in Zambian copper mine
Matrix Labs promoter sells 1.48 pc holding
Grandix Pharma to set up formulation plant near Chennai
TNPL plans to expand capacity — To invest Rs 595 cr
SPL plans expand Indian operations
Defying CLB order: Case filed against Morepen Labs
Ministry pulled up for drop in inspections of cos
Investor fund transfers: Ministry to condone delays
CIL sets its sights on coal gas
ONGC to enter petrol retailing by fiscal-end
Ford eyes 27,000 Ikons sales this year
JHV Group sees growth in liquor biz
Home networking to power Onkyo topline
Grand Hyatt(Mumbai) hopes to function full stream by January
Mundra SEZ hopes to bring rich NRIs back home
D.S. Brar `closely involved' in GVK group company
New Hyundai MD



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line